In a groundbreaking achievement, Peace and Love Hospital in Kumasi, Ghana, has become one of the first hospitals in the world to introduce a revolutionary technology that enables rapid diagnosis of breast cancer at the bedside. Led by Dr. Beatrice Wiafe Addai, the hospital has successfully implemented the CoreViewTM instrument, a game-changing innovation that delivers tissue-based diagnosis within 10 minutes of a biopsy procedure.
Traditionally, breast cancer diagnosis involves a lengthy process that can take days, weeks, or even months. However, with CoreView, pathologists can render a diagnosis immediately on-site, or digital images can be sent to experts worldwide for rapid evaluation. This technology has the potential to transform breast cancer care, enabling patients to receive timely treatment and improving health outcomes.
The CoreView technology was developed through a collaborative effort between Dr. Wiafe Addai and two principal investigators from the United States: Professor Richard Levenson of UC Davis and Professor Eric Seibel of the University of Washington, Seattle. This innovative solution can be deployed even in low-resource settings, making medical care more personal, efficient, and equitable.
Peace and Love Hospital’s pioneering achievement is a testament to the power of collaboration and innovation in healthcare. As the first hospital in the world to adopt this technology, it sets a new standard for breast cancer diagnosis and treatment. With CoreView, patients can now receive rapid diagnosis and treatment plans, improving their chances of survival and quality of life.
This breakthrough is a shining example of Ghana’s contribution to global healthcare innovation. As the world continues to grapple with the challenges of cancer diagnosis and treatment, Peace and Love Hospital’s achievement serves as a beacon of hope for patients and healthcare providers alike.